India now requires a doctor's prescription for the purchase of cough syrups nationwide [1].
This regulatory shift aims to curb the unsupervised use of syrup-based medicines that were previously treated as simple household remedies. By tightening these rules, the government seeks to prevent potential misuse and ensure patient safety through professional medical oversight.
The Ministry of Health and Family Welfare (MoHFW) implemented the change by amending the Drugs Rules, 1945 [1, 2]. Specifically, the ministry removed cough syrups from Schedule K, the list of drugs that can be sold without a prescription [1, 3].
Under the previous guidelines, many consumers could purchase these medications over-the-counter without medical consultation. The new mandate ensures that pharmacists can only dispense these syrups upon the presentation of a valid medical prescription [2, 4].
The government released the official order on June 9, 2024 [1]. This move marks a significant transition in how the Indian healthcare system manages the distribution of common respiratory medications, shifting them from general consumer goods to controlled pharmaceutical products.
Officials said the amendment is necessary to tighten regulations across the pharmaceutical sector [2, 3]. The move targets the systemic availability of these drugs to ensure they are used only when clinically indicated by a healthcare provider [4].
“India now requires a doctor's prescription for the purchase of cough syrups nationwide.”
This policy change represents a broader effort by the Indian government to reduce the prevalence of self-medication. By removing these products from Schedule K, the state is prioritizing clinical supervision over consumer convenience, likely to mitigate risks associated with incorrect dosage or the abuse of specific ingredients found in cough suppressants.
